secwatch / observer
8-K filed January 8, 2024, 6:59 PM ET ticker DXCM CIK 0001093557
earnings confidence high sentiment positive materiality 0.80

DexCom reports preliminary Q4 revenue ≥$1.03B (+26% YoY); FY2024 guidance $4.15-4.35B

DEXCOM INC

2023-FY EPS reported $1.30 revenue$3,622,300,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DEXCOM INC reported the fourth quarter ended December 31, 2023 results: revenue $1.030 billion.

Period
the fourth quarter ended December 31, 2023
Revenue
$1.030 billion
Result
preliminary results
Exact text from the filing
preliminary, unaudited revenue for the fourth quarter ended December 31, 2023 is expected to be at least $1.030 billion
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DEXCOM INC reported fiscal year 2024 results: revenue $4.15 billion to $4.35 billion. Guidance initiated.

Period
fiscal year 2024
Revenue
$4.15 billion to $4.35 billion
Guidance
initiated
Result
guidance update
Exact text from the filing
For 2024, Dexcom currently anticipates total revenue of approximately $4.15 billion to $4.35 billion
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

DEXCOM INC reported fiscal year 2023 results: revenue $3.62 billion.

Period
fiscal year 2023
Revenue
$3.62 billion
Result
preliminary results
Exact text from the filing
For fiscal year 2023, total preliminary, unaudited revenue is expected to be approximately $3.62 billion
View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

DEXCOM INC filing history →

Source: SEC EDGAR
accession 0001093557-24-000003
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.